Acceleron Pharma Inc. (XLRN) |
|
41.175 0.635 (1.57%)
|
04-25 15:57 |
|
Open: |
40.31 |
Pre. Close: |
40.54 |
|
High:
|
41.3 |
Low:
|
39.995 |
|
Volume:
|
94,950 |
Market Cap:
|
2169M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
41.795 - 42.034 |
42.034 - 42.251 |
|
Low:
|
39.974 - 40.233 |
40.233 - 40.466 |
|
Close:
|
40.17 - 40.582 |
40.582 - 40.955 |
|
|
|
Technical analysis |
as of: 2019-04-25 3:34:12 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 51.97 One year: 56.19 |
| Support: |
Support1: 38.65 Support2: 32.16 |
| Resistance: |
Resistance1: 44.50 Resistance2: 48.11 |
| Pivot: |
42.80  |
| Moving Average: |
MA(5): 40.57 MA(20): 43.72
MA(100): 44.30 MA(250): 45.32 |
| MACD: |
MACD(12,26): -1.25 Signal(9): -0.87 |
| Stochastic oscillator: |
%K(14,3): 26.28 %D(3): 22.44 |
| RSI: |
RSI(14): 40.64 |
| 52-week: |
High: 59.59 Low: 32.53 Change(%): 10.8 |
| Average Vol(K): |
3-Month: 36996 10-Days: 31856 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.XLRN has closed above bottom band by 30.0%. Bollinger Bands are 24.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 18 Apr 2019 16:10:21 Z
First Week of November 15th Options Trading For Acceleron Pharma (XLRN)
Tue, 09 Apr 2019 00:07:30 Z
Celgene & Acceleron Submit BLA for Luspatercept to the FDA
Thu, 21 Mar 2019 22:06:44 Z
Bullish Two Hundred Day Moving Average Cross - XLRN
Thu, 28 Feb 2019 09:08:37 Z
Acceleron Pharma (XLRN) Q4 2018 Earnings Conference Call Transcript
Wed, 20 Feb 2019 20:10:07 Z
Is Acceleron Pharma a Buy?
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
